摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-tert-Butyl-5,6-dimethyl-1H-benzoimidazole | 141472-92-6

中文名称
——
中文别名
——
英文名称
1-tert-Butyl-5,6-dimethyl-1H-benzoimidazole
英文别名
1-(1,1-Dimethylethyl)-5,6-dimethyl-1H-benzimidazole;1-tert-butyl-5,6-dimethylbenzimidazole
1-tert-Butyl-5,6-dimethyl-1H-benzoimidazole化学式
CAS
141472-92-6
化学式
C13H18N2
mdl
——
分子量
202.299
InChiKey
UYUOYQFYKAVWLS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    324.5±45.0 °C(Predicted)
  • 密度:
    1.00±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    5,6-二甲基苯并咪唑 、 alkaline earth salt of/the/ methylsulfuric acid 在 氢氧化钾 作用下, 以 乙醇 为溶剂, 以20%的产率得到1-tert-Butyl-5,6-dimethyl-1H-benzoimidazole
    参考文献:
    名称:
    Vlaovic, Djordje; Canadanovic-Brunet, Jasna; Balaz, Jelica, Bioscience, Biotechnology and Biochemistry, 1992, vol. 56, # 2.3.4., p. 199 - 206
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • THERAPEUTIC COMPOUNDS
    申请人:Gilead Sciences, Inc.
    公开号:US20140303164A1
    公开(公告)日:2014-10-09
    Compounds of formula I: or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
    公开了化学式I的化合物或其盐。还公开了包含化学式I化合物的药物组合物,制备化学式I化合物的方法,用于制备化学式I化合物的中间体以及治疗反转录病毒感染的治疗方法,包括由HIV病毒引起的感染。
  • Nonaqueous Electrolyte and Nonaqueous Secondary Battery
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:US20180062213A1
    公开(公告)日:2018-03-01
    The purpose of the present invention is to provide a nonaqueous electrolyte that contains acetonitrile having an excellent balance between viscosity and the dielectric constant and a fluorine-containing inorganic lithium salt, wherein the generation of complex cations comprising a transition metal and acetonitrile is suppressed, excellent load characteristics are exhibited, and increases in internal resistance upon repeated charge/discharge cycles are suppressed; a further purpose of the present invention is to provide a nonaqueous secondary battery. The present invention relates to a nonaqueous electrolyte which contains: a nonaqueous solvent comprising acetonitrile; a fluorine-containing inorganic lithium salt; and a specific nitrogenous cyclic compound typified by benzotriazole.
  • US9873680B2
    申请人:——
    公开号:US9873680B2
    公开(公告)日:2018-01-23
  • US9951043B2
    申请人:——
    公开号:US9951043B2
    公开(公告)日:2018-04-24
  • Vlaovic, Djordje; Canadanovic-Brunet, Jasna; Balaz, Jelica, Bioscience, Biotechnology and Biochemistry, 1992, vol. 56, # 2.3.4., p. 199 - 206
    作者:Vlaovic, Djordje、Canadanovic-Brunet, Jasna、Balaz, Jelica、Juranic, Ivan、Djokovic, Dejan、Mackenzie, Kenneth
    DOI:——
    日期:——
查看更多